Patrick L. Iversen

Statistics

Publications

177

Citations

10.5K

H-Index

Active since

1978

Affiliations

Sarepta Therapeutics (United States)(Current)

University of Nebraska Medical Center

Oregon State University

United States Army Medical Research Institute of Infectious Diseases

Corvallis Environmental Center

Patrick L. Iversen is an author at Sarepta Therapeutics (United States) specializing in morpholino oligomers, morpholino oligonucleotides, and life sciences.

ORCID

Publications per year

1978–2023

177

Publications

177

Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice

Natee Jearawiriyapaisarn, Hong M. Moulton, Brian K. Buckley et al. · Molecular Therapy · 2008 · 234 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

Bo Wu, Hong M. Moulton, Patrick L. Iversen et al. · Proceedings of the National Academy of Sciences · 2008 · 232 citations · Full text

Medicine, Biochemistry, Cardiology +10

Pharmacokinetics, Biodistribution, Stability and Toxicity of a Cell-Penetrating Peptide−Morpholino Oligomer Conjugate

Adams Amantana, Hong M. Moulton, Melissa L. Cate et al. · Bioconjugate Chemistry · 2007 · 206 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD

Graham McClorey, Hong M. Moulton, Patrick L. Iversen et al. · Gene Therapy · 2006 · 203 citations

Medicine, Cell Biology, Molecular Medicine +10

Advanced antisense therapies for postexposure protection against lethal filovirus infections

Travis K. Warren, Kelly L. Warfield, Jay Wells et al. · Nature Medicine · 2010 · 200 citations

Life Sciences, Immunology, Infectious Diseases +16

1–5 of 177